194 related articles for article (PubMed ID: 19955922)
1. B7-H4 expression promotes tumorigenesis in ovarian cancer.
Cheng L; Jiang J; Gao R; Wei S; Nan F; Li S; Kong B
Int J Gynecol Cancer; 2009 Dec; 19(9):1481-6. PubMed ID: 19955922
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
3. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
[TBL] [Abstract][Full Text] [Related]
4. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
[TBL] [Abstract][Full Text] [Related]
5. RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer.
Zheng C; Yang R
J BUON; 2019; 24(2):715-719. PubMed ID: 31128028
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
7. Role of B7-H4 siRNA in Proliferation, Migration, and Invasion of LOVO Colorectal Carcinoma Cell Line.
Peng HX; Wu WQ; Yang DM; Jing R; Li J; Zhou FL; Jin YF; Wang SY; Chu YM
Biomed Res Int; 2015; 2015():326981. PubMed ID: 26078947
[TBL] [Abstract][Full Text] [Related]
8. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].
Zhang W; Yang YZ; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.
Choi IH; Zhu G; Sica GL; Strome SE; Cheville JC; Lau JS; Zhu Y; Flies DB; Tamada K; Chen L
J Immunol; 2003 Nov; 171(9):4650-4. PubMed ID: 14568939
[TBL] [Abstract][Full Text] [Related]
10. The experimental study of ovarian carcinoma vaccine modified by human B7-1 and IFN-gamma genes.
Qian HN; Liu GZ; Cao SJ; Feng J; Ye X
Int J Gynecol Cancer; 2002; 12(1):80-5. PubMed ID: 11860540
[TBL] [Abstract][Full Text] [Related]
11. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
[TBL] [Abstract][Full Text] [Related]
12. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
Zhang X; Cai L; Zhang G; Shen Y; Huang J
Oncotarget; 2017 Mar; 8(12):18861-18871. PubMed ID: 28061481
[TBL] [Abstract][Full Text] [Related]
13. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
[TBL] [Abstract][Full Text] [Related]
14. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells.
Yao Y; Wang X; Jin K; Zhu J; Wang Y; Xiong S; Mao Y; Zhou L
J Neurooncol; 2008 Sep; 89(2):121-9. PubMed ID: 18478183
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases.
Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J
Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304
[TBL] [Abstract][Full Text] [Related]
16. B7-H4, a promising target for immunotherapy.
Wang JY; Wang WP
Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
[TBL] [Abstract][Full Text] [Related]
17. Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.
Smith JB; Lanitis E; Dangaj D; Buza E; Poussin M; Stashwick C; Scholler N; Powell DJ
Mol Ther; 2016 Nov; 24(11):1987-1999. PubMed ID: 27439899
[TBL] [Abstract][Full Text] [Related]
18. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
[TBL] [Abstract][Full Text] [Related]
19. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
20. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
